Try our beta test site
64 studies found for:    burzynski
Show Display Options
RSS Create an RSS feed from your search for:
burzynski
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
2 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
3 Unknown  Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Condition: Carcinoma of Unknown Primary
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
4 Unknown  Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
5 Completed Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
6 Terminated Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
7 Unknown  Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
8 Unknown  Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
9 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Condition: Lung Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
10 Terminated Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
Condition: Esophageal Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
11 Unknown  Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
12 Unknown  Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
13 Unknown  Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
14 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Condition: Adrenocortical Carcinoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
15 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer or Stage IV Newly Diagnosed, Incurable Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
16 Active, not recruiting A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
Condition: Diffuse, Intrinsic Pontine Glioma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
17 Completed
Has Results
Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
Condition: Childhood CNS Primitive Neuroectodermal Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
18 Terminated Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Condition: CNS Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
19 Completed
Has Results
Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
Condition: Adult Brain Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
20 Withdrawn Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
Conditions: Stage IV Breast Cancer;   Recurrent Breast Cancer
Interventions: Drug: antineoplaston A10;   Drug: methotrexate;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: chemotherapy;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.